Yaz® and Yazmin® are pregnancy prevention medications that combine droperinone (progestin) and ethinyl estradiol (estrogen). Since their introduction to the market in 2001 by Bayer Pharmaceuticals, Yaz and Yazmin have become one of the most popular contraceptives in use. However, in recent years a link between the use of these drugs and blood clots has been established. In many cases, these clots can lead to even more serious and potentially deadly complications such as embolisms and deep vein thrombosis.
These drugs have been the subject of numerous lawsuits alleging that Bayer, the manufacturer of these drugs, failed to adequately warn users of these potentially lethal complications.
How Yaz/Yazmin Works
Yaz/Yazmin are progesterone and estrogen combination birth control pills. They work by preventing ovulation, thickening the mucus in the cervix, and changing the lining of the uterus.
Yaz/Yazmin prevent ovulation by “tricking” the body into believing it is pregnant which prevents the ovulation process (the release of an egg into the fallopian tube). Yaz/Yazmin also prevent pregnancy by thickening the cervical mucus which inhibits the ability of sperm to travel to the egg for fertilization.
When taken appropriately, Yaz and Yazmin are 99% effective at preventing pregnancy.
Yaz and Yazmin Complications and Side Effects
In 2011, the FDA released the results of a study of 100,000 women who took oral contraceptives like Yaz. The FDA reported that that women taking drugs like Yaz were at a 75% higher risk of developing blood clots than women who were on traditional birth control.
The development of blood clots in the body can lead to much more serious conditions such as strokes, pulmonary embolism, and even deep vein thrombosis. The FDA has received thousands of reports of adverse event reports from Yaz users including various reports of severe injury and in some cases even death.
Bayer has been the subject of hundreds of lawsuits alleging it failed to adequately warn women of the potentially deadly complications of Yaz/Yazmin use. As a result of the litigation and recent scientific studies finding Yaz users at a much higher risk of blood clots than other contraceptive users, Bayer has started to give financial compensation to Yaz/Yazmin users who suffered from severe complications such a blood clots, deep vein thrombosis, stroke or embolisms. Bayer has already paid out more than $400 million in settlements and many legal/health experts suggest that Bayer could end up paying more than $2 billion in settlements.
If you or a family member took Yaz, Yazmin or Ocella and suffered a blood clot, deep vein thrombosis, embolism or stoke, please contact our firm for a free legal consultation about your rights.